18078350|t|Alzheimer's Abeta peptides containing an isostructural backbone mutation afford distinct aggregate morphologies but analogous cytotoxicity. Evidence for a common low-abundance toxic structure(s)?
18078350|a|Amyloid beta (Abeta) peptide amyloidogenesis, involving the formation of numerous distinct quaternary structures, appears to cause Alzheimer's disease. However, the precise identification of the toxic structure(s) and the neurotoxicity mechanism(s) remains elusive. Mutating the Abeta 1-40 Phe19-Phe20 backbone amide bond to an isostructural E-olefin bond enables formation of spherical aggregates to the exclusion of detectable amyloid fibrils. Herein, the fibrillization and toxicity of amide-to-ester mutants of Abeta 1-40 at the 19-20 position and surrounding backbone amide bonds are compared to the fibrillization and toxicity of the 19-20 E-olefin Abeta analogue and wild type Abeta. Whereas isostructural amide-to-E-olefin mutations eliminate both the H-bond donor and acceptor capabilities, isostructural amide-to-ester mutations eliminate the donor while retaining the ester carbonyl as a weakened acceptor. None of the amide-to-ester Abeta 1-40 mutants prevent fibrillization; in fact several exhibit hastened amyloidogenesis. The 18-19 amide-to-ester substitution is the only backbone mutation within the hydrophobic core region of the fibril (residues 17-21) that significantly slows fibrillization. Despite forming different morphologies, the 19-20 E-olefin mutant, the 18-19 amide-to-ester mutant, and WT Abeta 1-40 fibrils all exhibit similar toxicities when applied to PC12 cells at 18 h into the aggregation reactions, as assessed by MTT metabolic activity measurements. This result suggests that a common but low abundance aggregate morphology, that is accessible to these Abeta analogues, mediates toxicity, or that several different aggregate morphologies are similarly toxic.
18078350	0	11	Alzheimer's	Disease	MESH:D000544
18078350	12	17	Abeta	Gene	54226
18078350	126	138	cytotoxicity	Disease	MESH:D064420
18078350	210	215	Abeta	Gene	54226
18078350	327	346	Alzheimer's disease	Disease	MESH:D000544
18078350	418	431	neurotoxicity	Disease	MESH:D020258
18078350	507	512	amide	Chemical	MESH:D000577
18078350	538	546	E-olefin	Chemical	-
18078350	673	681	toxicity	Disease	MESH:D064420
18078350	685	690	amide	Chemical	MESH:D000577
18078350	694	699	ester	Chemical	MESH:D004952
18078350	769	774	amide	Chemical	MESH:D000577
18078350	820	828	toxicity	Disease	MESH:D064420
18078350	836	850	19-20 E-olefin	Chemical	-
18078350	851	856	Abeta	Gene	54226
18078350	880	885	Abeta	Gene	54226
18078350	909	914	amide	Chemical	MESH:D000577
18078350	918	926	E-olefin	Chemical	-
18078350	1010	1015	amide	Chemical	MESH:D000577
18078350	1019	1024	ester	Chemical	MESH:D004952
18078350	1075	1080	ester	Chemical	MESH:D004952
18078350	1126	1135	amide-to-	Chemical	-
18078350	1135	1140	ester	Chemical	MESH:D004952
18078350	1244	1249	amide	Chemical	MESH:D000577
18078350	1253	1258	ester	Chemical	MESH:D004952
18078350	1453	1467	19-20 E-olefin	Chemical	-
18078350	1486	1491	amide	Chemical	MESH:D000577
18078350	1495	1500	ester	Chemical	MESH:D004952
18078350	1555	1565	toxicities	Disease	MESH:D064420
18078350	1582	1586	PC12	CellLine	CVCL:0481
18078350	1648	1651	MTT	Chemical	MESH:C070243
18078350	1788	1793	Abeta	Gene	54226
18078350	1814	1822	toxicity	Disease	MESH:D064420
18078350	Association	MESH:D064420	54226
18078350	Association	MESH:D000544	54226
18078350	Association	MESH:D000577	MESH:D004952

